Gilead Sciences (GILD) Tops Q4 EPS by 17c; Guides

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Gilead Sciences (GILD) Tops Q4 EPS by 17c; Guides

Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend

February 2, 2023 4:05 PM EST

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the companys Board of Directors has declared an increase of 2.7% in the companys quarterly cash dividend, beginning in the first quarter of 2023. The increase will result in a... More

Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results

February 2, 2023 4:01 PM EST

Product Sales Excluding Veklury Increased Year-Over-Year by 8% for Full Year 2022

Biktarvy Sales Increased Year-Over-Year by 20% for Full Year 2022

Oncology Sales Increased Year-Over-Year by 71% for Full Year 2022

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2022.

2022 marked Gileads strongest full year growth in our base business since HCV sales peaked in 2015. This return to growth was driven by consistent and high quality... More